SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
4,450.00    0.00 (0.00%)
Bid:
4,400.00
Ask:
4,580.00
Spread: 180.00 (4.091%)
Market Cap: £296.40m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Directorate Change

23 May 2018 07:00

RNS Number : 9323O
Judges Scientific PLC
23 May 2018
 

Judges Scientific plc (the "Group", "Company" or "Judges")

Board changes

 

The Board of Judges Scientific, a group involved in the buy and build of scientific instrument businesses, announces the following board changes.

Charles Holroyd will join the Group as an Independent Non-Executive Director. Glynn Reece, Non-Executive Director, will be stepping down from the Board but will remain with the Group in the role of Company Secretary. The changes will take effect from 1 June 2018.

Charles has a BSc in Electrical and Electronics Engineering from Bristol University and an MBA from INSEAD and is a Chartered Engineer and a Fellow of the Institution of Engineering and Technology. Charles has held senior management positions within a number of publicly quoted companies. Most recently Charles worked at Oxford Instruments plc, which he joined in 1999 and where he served on the board from 2005 until 2013 and was responsible for group business development.

Following the above changes, the Board committees will comprise as follows:

Audit committee

Charles will join as a member of the audit committee. Following his appointment the audit committee comprise of three members being Ralph Elman, Ralph Cohen and Charles Holroyd with Ralph Elman acting as Chairman

Remuneration committee

Charles will join as a member of the remuneration committee. Following his appointment the remuneration committee will comprise of three members being Alex Hambro, Ralph Cohen and Charles Holroyd with Alex Hambro acting as Chairman

Commenting on the appointment, Alex Hambro, Chairman of Judges, said

"We are delighted to welcome Charles to the Group. Charles brings extensive knowledge of the scientific instrument sector in which we operate and we look forward to his guidance over the coming years as the Group continues to execute its buy and build growth strategy.

"On behalf of the Board, I would like to thank Glynn for his counsel and contribution to the Group as a Non-Executive Director and welcome his continued activity as our Company Secretary. Having been with the Group since its inception, he has worked with the Board to grow the business and deliver significantly value for our shareholders. His involvement has been hugely valued."

 

Regulatory Information

Charles John Arthur Holroyd, aged 62, currently holds, and has held (including all appointments during the five years preceding the date of this announcement), the following directorships and partnerships, other than of the Company:

Current Directorships

Phase Focus Limited

 

 

Past Directorships

HKL Technology A/S

Molecular Warehouse Limited 

Oxford Instruments Plc

Oxford Instruments Asylum Research Inc

Oxford Instruments Holdings Europe Limited

Oxford Instruments India Private Limited

Oxford Instruments Industrial Products Limited

Oxford Instruments Industrial Products Holdings Limited

Oxford Instruments Nanotechnology Tools Limited

Oxford Instruments Nordiska AB

Oxford Instruments Overseas Holdings Limited

Oxford Instruments Overseas Holdings 2008 Limited

Oxford Instruments Private Limited

Oxford Instruments SAS

Oxford Instruments Technology (Shanghai) Company Limited

Oxford Instruments UK 2013 Limited

Scienta Omicron

 

Charles Holroyd has confirmed that there is no other additional information to be disclosed under Schedule 2 (g) of the AIM Rules.

 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group involved in the buy and build of scientific instrument businesses. The Group currently consists of 16 businesses acquired since it was re-admitted to AIM in 2005.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queens' awards for innovation and export.

Judges Scientific maintains a policy to selectively acquire businesses that generate sustainable profits and cash. Shareholder returns are created through the repayment of debt, dividends and through organic growth which the Group encourages by creating an environment for businesses to thrive in, with support and advice for entity management teams.

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

For further information, please visit www.judges.uk.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAPGUACAUPRGAP
Date   Source Headline
30th Mar 20123:49 pmRNSDirector/PDMR Shareholding and Exercise of Options
29th Mar 20127:00 amRNSFinal Results
12th Mar 20126:17 pmRNSHolding(s) in Company
7th Mar 20127:00 amRNSACQUISITION OF GLOBAL DIGITAL SYSTEMS LIMITED
22nd Feb 201210:00 amRNSAcquisition of KE Developments Limited
19th Jan 20127:00 amRNSTrading Statement
16th Nov 20117:00 amRNSTrading Statement
6th Oct 201111:59 amRNSDirector/PDMR Shareholding and Exercise of Options
28th Sep 20117:00 amRNSHalf Yearly Report
14th Sep 20117:00 amRNSNotice of Results
22nd Jul 20115:04 pmRNSDirector/PDMR Shareholding
18th Jul 20117:00 amRNSTrading Statement
27th May 20117:00 amRNSIssue of Equity
26th May 20114:28 pmRNSDirector/PDMR Shareholding
10th May 20117:00 amRNSDirector/PDMR Shareholding
28th Apr 20119:25 amRNSHolding(s) in Company
15th Apr 20115:03 pmRNSDirector/PDMR Shareholding
7th Apr 20112:48 pmRNSHolding(s) in Company
5th Apr 20116:05 pmRNSDirector/PDMR Shareholding
5th Apr 20115:44 pmRNSDirector/PDMR Shareholding
4th Apr 20116:28 pmRNSDirector/PDMR Shareholding
1st Apr 201110:51 amRNSHolding(s) in Company
30th Mar 20117:00 amRNSFinal Results
21st Mar 20117:00 amRNSAcquisition
4th Mar 20117:00 amRNSNotice of Results
20th Jan 20117:00 amRNSTrading Statement
13th Jan 201111:10 amRNSDirector/PDMR Shareholding
22nd Nov 20105:20 pmRNSExercise of options
17th Nov 20107:00 amRNSTrading Statement
11th Oct 20106:17 pmRNSHolding(s) in Company
28th Sep 20107:00 amRNSExercise of Options
22nd Sep 20107:00 amRNSHalf Yearly Report
9th Sep 20102:00 pmRNSNotice of Results
21st Jul 201012:08 pmRNSHolding(s) in Company
20th Jul 201012:04 pmRNSHolding(s) in Company
20th Jul 20109:13 amRNSDirector/PDMR Shareholding
16th Jul 20107:00 amRNSTrading Statement
25th May 201012:17 pmRNSResult of AGM
21st May 20109:35 amRNSIssue of Equity
26th Mar 20107:00 amRNSFinal Results
19th Mar 20107:00 amRNSAcquisition
4th Mar 20105:25 pmRNSNotice of Results
22nd Jan 201011:15 amRNSShare buyback programme
22nd Jan 20107:00 amRNSTrading Statement
14th Jan 201010:20 amRNSHolding(s) in Company
11th Dec 20097:00 amRNSTrading Statement
20th Oct 200910:55 amRNSExercise of options
2nd Oct 20097:00 amRNSDirector/PDMR Shareholding
29th Sep 20097:00 amRNSHalf Yearly Report
22nd Sep 20097:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.